Conditions: Autistic Disorder Attention Deficit Disorder With Hyperactivity
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 97
Healthy volunteers: no

Brief summary:
The purpose of this study is to determine whether atomoxetine is effective in reducing ADHD (Attention Deficit/Hyperactivity Disorder) symptoms in children and adolescents with ASD (Autism Spectrum Disorder).

Detailed description:

Arms:
arm 1: atomoxetine 0.5 mg/kg/day every day (QD), by mouth (PO) for 1 week, atomoxetine 0.8mg/kg/day QD, PO for 1 week, 1.2mg/kg/day QD, PO for 6 weeks then atomoxetine 0.5-1.2 mg/kg/day QD, PO for up to 20 weeks arm 2: placebo every day (QD), by mouth (PO) for 8 weeks

Then patients can take atomoxetine 0.5-1.2 mg/kg/day QD, PO up to 20 weeks

Interventions: intervention 1: Atomoxetine intervention 2: Placebo
Intervention descriptions: intervention 1: None intervention 2: None

Protocol document: